10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0000946644-13-000017`
Period End Date	20130630
Filing Date	20130809
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	heb-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 8 Cash Flow Statement 62 Stockholders Equity 2 Comprehensive Income 73

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value per share (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Preferred stock, issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable securities unrestricted	`AvailableForSaleSecuritiesCurrent`	$16.84M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities unrestricted	`AvailableForSaleSecuritiesCurrent`	$27.24M	USD	Point-in-time
Preferred stock, outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Marketable securities restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$14.37M	USD	Point-in-time
Marketable securities restricted	`AvailableforsaleSecuritiesRestrictedCurrent`	$14.50M	USD	Point-in-time
Inventories	`InventoryWorkInProcess`	-	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Inventories	`InventoryWorkInProcess`	$453.00K	USD	Point-in-time
Inventories	`InventoryWorkInProcess`	$897.00K	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	166.49M	shares	Point-in-time
Common stock, issued	`CommonStockSharesIssued`	167.23M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$359.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseCurrent`	$322.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	167.23M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$32.88M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$44.73M	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	166.49M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.99M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$5.29M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.07M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$1.03M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$6.58M	USD	Point-in-time
Construction in progress	`ConstructionInProgressGross`	$7.07M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$65.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$136.00K	USD	Point-in-time
Total assets	`Assets`	$57.70M	USD	Point-in-time
Total assets	`Assets`	$46.14M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$967.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.16M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.40M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.80M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$7.05M	USD	Point-in-time
Margin account loan	`MarginAccountLoanLiability`	$7.05M	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$46.00K	USD	Point-in-time
Current portion of capital lease	`CapitalLeaseObligationsCurrent`	$35.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.86M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$12.65M	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$37.00K	USD	Point-in-time
Long-term portion of capital lease	`CapitalLeaseObligationsNoncurrent`	$55.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$104.00K	USD	Point-in-time
Redeemable warrants	`DerivativeLiabilitiesNoncurrent`	$295.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$13.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.00M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01 per share, authorized 5,000,000; issued and outstanding; none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 167, 229,903 and 166,490,190, respectively	`CommonStockValue`	$167.00K	USD	Point-in-time
Common stock, par value $0.001 per share, authorized 350,000,000 shares; issued and outstanding 167, 229,903 and 166,490,190, respectively	`CommonStockValue`	$166.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$289.05M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$288.67M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.09M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-43.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-251.99M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-244.09M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$44.70M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$46.14M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$57.70M	USD	Point-in-time

Income Statement 8 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$44.70M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.14M	USD	Point-in-time
Stock issued for settlement of accounts payable	`StockIssuedForSettlementOfAccountsPayable`	$164.00K	USD	2 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$90.00K	USD	2 Qtrs
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$219.00K	USD	2 Qtrs
Net comprehensive loss	`OtherComprehensiveIncomeLossNetOfTax`	$-8.94M	USD	2 Qtrs
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$44.70M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$36.14M	USD	Point-in-time

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-5.31M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-3.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.89M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.28M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$296.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$350.00K	USD	2 Qtrs
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$87.00K	USD	2 Qtrs
Amortization of patent and trademark rights	`AdjustmentForAmortization`	$5.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$102.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$387.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$191.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$236.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$90.00K	USD	2 Qtrs
Equity-based compensation	`StockOptionPlanExpense`	$219.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-453.00K	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$211.00K	USD	2 Qtrs
Increase (Decrease) in Prepaid Expense and Other Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$37.00K	USD	2 Qtrs
Increase (Decrease) in Prepaid Expense and Other Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-106.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-1.03M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$256.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.59M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-476.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.63M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.48M	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.21M	USD	2 Qtrs
Purchase of property, equipment and construction in progress	`PaymentsToAcquirePropertyPlantAndEquipment`	$534.00K	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$28.00K	USD	2 Qtrs
Additions to patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$122.00K	USD	2 Qtrs
Deposits on capital leases refunded	`PaymentsToAcquireEquipmentOnLease`	$-7.00K	USD	2 Qtrs
Deposits on capital leases refunded	`PaymentsToAcquireEquipmentOnLease`	$-3.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	$74.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpense`	-	USD	2 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$7.22M	USD	2 Qtrs
Maturities of short-term and long-term marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$9.48M	USD	2 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	$2.06M	USD	2 Qtrs
Purchase of short-term and long-term marketable securities	`PaymentsToAcquireMarketableSecurities`	-	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.93M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$8.75M	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$29.00K	USD	2 Qtrs
Payments on capital leases	`RepaymentsOfLongTermCapitalLeaseObligations`	$25.00K	USD	2 Qtrs
Proceeds from margin account loan	`ProceedsFromMarginAccountLoan`	-	USD	2 Qtrs
Proceeds from margin account loan	`ProceedsFromMarginAccountLoan`	$2.64M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.62M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-29.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-933.00K	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-906.00K	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.31M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.31M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.17M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.21M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$3.10M	USD	Point-in-time
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$133.00K	USD	2 Qtrs
Issuance of common stock for accounts payable and accrued expenses	`IssuanceOfCommonStockForAccountsPayableAndAccruedExpenses`	$164.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-1.04M	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$655.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$191.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`AdjustmentOfWarrantsGrantedForServices`	$236.00K	USD	2 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	$-33.00K	USD	2 Qtrs
Cash paid for interest expense and capitalized construction interest	`InterestExpense`	$-98.00K	USD	2 Qtrs

Stockholders Equity 2 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time

Comprehensive Income 73 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs	`SalesRevenueGoodsNet`	$49.00K	USD	1 Quarter
Clinical treatment programs	`SalesRevenueGoodsNet`	$121.00K	USD	2 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$78.00K	USD	2 Qtrs
Clinical treatment programs	`SalesRevenueGoodsNet`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$36.00K	USD	1 Quarter
Total revenues	`Revenues`	$78.00K	USD	2 Qtrs
Total revenues	`Revenues`	$49.00K	USD	1 Quarter
Total revenues	`Revenues`	$121.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$826.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$208.00K	USD	1 Quarter
Production/cost of goods sold	`CostOfRevenue`	$488.00K	USD	2 Qtrs
Production/cost of goods sold	`CostOfRevenue`	$635.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.32M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.65M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.74M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.40M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.89M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.82M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.74M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$3.61M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$9.37M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$3.68M	USD	1 Quarter
Total costs and expenses	`CostsAndExpenses`	$7.50M	USD	2 Qtrs
Total costs and expenses	`CostsAndExpenses`	$4.77M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.63M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.73M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-9.30M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-7.38M	USD	2 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$5.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$1.00K	USD	1 Quarter
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$12.00K	USD	2 Qtrs
Interest expense	`InterestExpenseLesseeAssetsUnderCapitalLease`	$10.00K	USD	2 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$354.00K	USD	1 Quarter
Interest and other income	`OtherInterestAndDividendIncome`	$520.00K	USD	2 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$535.00K	USD	2 Qtrs
Interest and other income	`OtherInterestAndDividendIncome`	$247.00K	USD	1 Quarter
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$1.33M	USD	2 Qtrs
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$686.00K	USD	2 Qtrs
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	$685.00K	USD	Point-in-time
Funds received from sale of income tax net operating losses	`FundsReceivedFromSaleOfIncomeTaxNetOperatingLosses`	-	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$102.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$387.00K	USD	1 Quarter
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$191.00K	USD	2 Qtrs
Redeemable warrants valuation adjustment	`DerivativeGainOnDerivative`	$236.00K	USD	2 Qtrs
Net loss	`ProfitLoss`	$-5.31M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-3.00M	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.89M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-4.28M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$584.00K	USD	2 Qtrs
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-1.00M	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$187.00K	USD	1 Quarter
Unrealized gain (loss) on marketable securities	`UnrealizedGainLossOnInvestments`	$-960.00K	USD	2 Qtrs
Realized loss on securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-87.00K	USD	2 Qtrs
Realized loss on securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-37.00K	USD	2 Qtrs
Realized loss on securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-21.00K	USD	1 Quarter
Realized loss on securities	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-77.00K	USD	1 Quarter
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$1.00K	USD	1 Quarter
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$108.00K	USD	2 Qtrs
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$2.00K	USD	2 Qtrs
Less: Premium amortization	`OtherComprehensiveIncomeLossReclassificationAdjustmentForWritedownOfSecuritiesIncludedInNetIncomeNetOfTax`	$48.00K	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-8.94M	USD	2 Qtrs
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-5.36M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-2.79M	USD	1 Quarter
Net comprehensive loss	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-4.65M	USD	2 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted loss per share (usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.05	USD	2 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.88M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.01M	shares	2 Qtrs
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	135.97M	shares	1 Quarter
Weighted average shares outstanding, basic and diluted (shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	167.20M	shares	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.